TERT and breast carcinoma: Although previous literature presented variants rs2736107, rs2736108 and rs2736109 but not rs2853669 as variants effective in reducing TERT promoter activity [41, 42], we now show that this result was probably influenced by non-breast cancer risk associated variants present in the constructs used in prior studies.